The Host Defense Peptide Cathelicidin Is Required for NK Cell-Mediated Suppression of Tumor Growth

被引:62
作者
Buechau, Amanda S. [1 ,3 ,4 ,5 ]
Morizane, Shin [1 ,3 ,4 ,5 ]
Trowbridge, Janet [1 ,3 ,4 ,5 ]
Schauber, Juergen [1 ,3 ,4 ,5 ]
Kotol, Paul [1 ,3 ,4 ,5 ]
Bui, Jack D. [2 ]
Gallo, Richard L. [1 ,3 ,4 ,5 ]
机构
[1] Univ Calif San Diego, Div Dermatol, Dept Med, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA
[3] VA Healthcare Syst, San Diego, CA 92103 USA
[4] Univ Munich, Klin Dermatol & Allergol, Munich, Germany
[5] Stadt Klinikum Munchen GmbH, Munich, Germany
基金
美国国家卫生研究院;
关键词
INVASIVE BACTERIAL-INFECTION; GROUP-A STREPTOCOCCUS; NATURAL-KILLER-CELLS; POLY I-C; ANTIMICROBIAL-PEPTIDE; CUTTING EDGE; GENE-EXPRESSION; FLOW-CYTOMETRY; DEFICIENT MICE; OVARIAN-CANCER;
D O I
10.4049/jimmunol.0902110
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
071005 [微生物学]; 100108 [医学免疫学];
摘要
Tumor surveillance requires the interaction of multiple molecules and cells that participate in innate and the adaptive immunity. Cathelicidin was initially identified as an antimicrobial peptide, although it is now clear that it fulfills a variety of immune functions beyond microbial killing. Recent data have suggested contrasting roles for cathelicidin in tumor development. Because its role in tumor surveillance is not well understood, we investigated the requirement of cathelicidin in controlling transplantable tumors in mice. Cathelicidin was observed to be abundant in tumor-infiltrating NK1.1(+) cells in mice. The importance of this finding was demonstrated by the fact that cathelicidin knockout mice (Camp(-/-)) permitted faster tumor growth than wild type controls in two different xenograft tumor mouse models (B16.F10 and RMA-S). Functional in vitro analyses found that NK cells derived from Camp(-/-) versus wild type mice showed impaired cytotoxic activity toward tumor targets. These findings could not be solely attributed to an observed perforin deficiency in freshly isolated Camp(-/-) NK cells, because this deficiency could be partially restored by IL-2 treatment, whereas cytotoxic activity was still defective in IL-2-activated Camp(-/-) NK cells. Thus, we demonstrate a previously unrecognized role of cathelicidin in NK cell antitumor function. The Journal of Immunology, 2010, 184: 369-378.
引用
收藏
页码:369 / 378
页数:10
相关论文
共 68 条
[1]
The human antimicrobial and chemotactic peptides LL-37 and α-defensins are expressed by specific lymphocyte and monocyte populations [J].
Agerberth, B ;
Charo, J ;
Werr, J ;
Olsson, B ;
Idali, F ;
Lindbom, L ;
Kiessling, R ;
Jörnvall, H ;
Wigzell, H ;
Gudmundsson, GH .
BLOOD, 2000, 96 (09) :3086-3093
[2]
Protein Kinase C-θ Is Required for NK Cell Activation and In Vivo Control of Tumor Progression [J].
Aguilo, Juan I. ;
Garaude, Johan ;
Pardo, Julian ;
Villalba, Martin ;
Anel, Alberto .
JOURNAL OF IMMUNOLOGY, 2009, 182 (04) :1972-1981
[3]
Keratinocytes store the antimicrobial peptide cathelicidin in lamellar bodies [J].
Braff, MH ;
Di Nardo, A ;
Gallo, RL .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 124 (02) :394-400
[4]
Innate immunity and antimicrobial defense systems in psoriasis [J].
Buchau, Amanda S. ;
Gallo, Richard L. .
CLINICS IN DERMATOLOGY, 2007, 25 (06) :616-624
[5]
Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes? [J].
Bui, Jack D. ;
Schreiber, Robert D. .
CURRENT OPINION IN IMMUNOLOGY, 2007, 19 (02) :203-208
[6]
Transcriptional regulator Id2 mediates CD8+ T cell immunity [J].
Cannarile, Michael A. ;
Lind, Nicholas A. ;
Rivera, Richard ;
Sheridan, Alison D. ;
Camfield, Kristin A. ;
Wu, Bei Bei ;
Cheung, Kitty P. ;
Ding, Zhaoqing ;
Goldrath, Ananda W. .
NATURE IMMUNOLOGY, 2006, 7 (12) :1317-1325
[7]
CHANG L, 1993, J IMMUNOL METHODS, V166, P45
[8]
The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection [J].
Chromek, Milan ;
Slamova, Zuzana ;
Bergman, Peter ;
Kovacs, Laszlo ;
Podracka, L'udmila ;
Ehren, Ingrid ;
Hokfelt, Tomas ;
Gudmundsson, Gudmundur H. ;
Gallo, Richard L. ;
Agerberth, Birgitta ;
Brauner, Annelie .
NATURE MEDICINE, 2006, 12 (06) :636-641
[9]
Treatment with LL-37 Peptide Enhances Antitumor Effects Induced by CpG Oligodeoxynucleotides Against Ovarian Cancer [J].
Chuang, Chi-Mu ;
Monie, Archana ;
Wu, Annie ;
Mao, Chih-Ping ;
Hung, Chien-Fu .
HUMAN GENE THERAPY, 2009, 20 (04) :303-313
[10]
Chun M, 1982, Lymphokine Res, V1, P91